Clinical Trial Update: A Study of Inhalation of 20,000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic Individuals [Phase 1]

View source ↗

Summary

Phase 1 trial comparing inhalation of an investigational agent (CCRE) in normal volunteers and allergic asthmatics has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Investigational inhalation agent (CCRE) (CCRE inhalation)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Asthma, Hypersensitivity | Phase 1 | Status: COMPLETED